Whitehawk Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Whitehawk Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Whitehawk Therapeutics Inc.
Rating: 2.45058325
Author: Trendlyne DVM scores

about

Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engine...

3.91 0.01 (0.26%)

New 52W High in past week

212.3K

XNAS Volume

XNAS 13 Mar, 2026 5:30 PM (EDT)

Board Meeting

The next board meeting for Whitehawk Therapeutics Inc is on 19 Mar 2026 for the purpose of Aadi Bioscience Inc Fourth Quarter Earnings Results for 2025 See details

Not Eligible

Expensive Valuation

18.8 / 100

Technically Bullish

79.2 / 100

1Yr Price target upside is 28%

3 analysts

Whitehawk Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Whitehawk Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engine...

New 52W High in past week

SWOT Analysis

Whitehawk Therapeutics Inc Live Price Chart